Tumor-associated ganglio-N-triosylceramide. Target for antibody-dependent, avidin-mediated drug killing of tumor cells.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D000936:Antigen-Antibody Complex; D001360:Avidin / Q000494:pharmacology; D001710:Biotin / Q000494:pharmacology; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002472:Cell Transformation, Viral; D003609:Dactinomycin / Q000494:pharmacology; D005677:G(M1) Ganglioside / Q000276:immunology / Q000502:physiology*; D005779:Immunodiffusion; D007708:Kirsten murine sarcoma virus; D007940:Leukemia L5178 / Q000503:physiopathology*; D007942:Leukemia, Experimental / Q000503:physiopathology*; D008081:Liposomes; D051379:Mice; D010714:Phosphatidylethanolamines / Q000494:pharmacology; D009353:Zinostatin / Q000494:pharmacology*
D000903:Antibiotics, Antineoplastic; D000936:Antigen-Antibody Complex; D008081:Liposomes; D010714:Phosphatidylethanolamines; D001360:Avidin; D003609:Dactinomycin; D005677:G(M1) Ganglioside; D001710:Biotin; D009353:Zinostatin